FDA Inspection 783591 — Tissue Transplant Technology, Ltd.

Tissue Transplant Technology, Ltd. — FEI 3000779542

The FDA completed an inspection of Tissue Transplant Technology, Ltd. on May 25, 2012 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 25, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
1233621 CFR 1271.180(a)Procedures to meet core CTGP

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.